glp-1 estrogen For women, hormones can be the deciding factor on how well GLP-1s work. It turns out HRT plus GLP-1s might be the answer. A patient came to see me in her mid-40s Sex-specific metabolic and central effects

An audit trail was kept to establish the confirmability of our findings

Current evidence on GLP-1 medications while breastfeeding The evidence we have is still small

What the clinical evidence actually says about semaglutide and UTIs Start with the data

While hypothesised to improve hepatocyte mitochondrial function and turnover, decrease mitochondrial oxidative stress, and decrease stellate cell activation, the anti-inflammatory and anti-fibrotic benefits of glucagon receptor agonism are more likely a consequence of overall reduction in hepatic steatosis [28, 75]

For the time being, though, the market is still dominated by two names: Eli Lilly and Co

These diabetes and weight loss medications are not for everyone